Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Published:2008-01-27 Issue:2 Volume:85 Page:256-263
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Gillard Pieter,Ling Zhidong,Mathieu Chantal,Crenier Laurent,Lannoo Matthias,Maes Bart,Roep Bart,Gorus Frans,Pipeleers Daniel,Keymeulen Bart

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference43 articles.

1. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.;Shapiro;N Engl J Med,2000

2. Five-year follow-up after clinical islet transplantation.;Ryan;Diabetes,2005

3. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control.;Ryan;Diabetes,2002

4. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: Analysis of incidence and risk factors.;Maes;Transplantation,2001

5. Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future.;de Mattos;Am J Kidney Dis,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens;Transplant International;2023-06-08

2. Islet Allotransplantation;Transplantation of the Pancreas;2023

3. Lessons Learned from Clinical Trials of Islet Transplantation;Pluripotent Stem Cell Therapy for Diabetes;2023

4. Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re‐emerging phenotype is associated with graft function;American Journal of Transplantation;2020-09-19

5. Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression;Transplantation;2017-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3